• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MedImmune

MedImmune

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Global Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or IGF-1) Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: AnGes, Digna Biotech, MedImmune - ...

    Global Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or IGF-1) Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: AnGes, Digna Biotech, MedImmune - Research and Markets

  2. Prophylactic Human Vaccines Market, 2022: Pediatric Prophylactic Vaccines, and Adult Prophylactic Vaccines - Global Strategic Business Report 2016 - Research and Markets

    Prophylactic Human Vaccines Market, 2022: Pediatric Prophylactic Vaccines, and Adult Prophylactic Vaccines - Global Strategic Business Report 2016 - Research and Markets

  3. GCC Countries Anti-Viral Drugs Market Outlook (2016-2021) - Key Players are Abbott, Gilead & GlaxoSmithKline - Research and Markets

    GCC Countries Anti-Viral Drugs Market Outlook (2016-2021) - Key Players are Abbott, Gilead & GlaxoSmithKline - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.